Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial Data

Stocks Yahoo Finance By Yahoo Finance 05 Jun 2026 16:36 1 min read

Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial Data

Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial Data

Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial Data

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.